Carrillo-Esper R, Elizondo-Argueta S, Sánchez-Zúñiga MJ, Carrillo-Córdova JR

Language: Spanish
References: 19
Page: 83-86
PDF size: 80.70 Kb.

ABSTRACT

Alveolar hemorrhage is a severe complication of systemic lupus erithematosus (SLe) associated with high mortality. Treatment includes administration of steroids and cyclophosphamide. Additionally, some reports have recommended the use of plasmapheresis, azathioprine and methotrexate. There is a single case reported in the literature in which recombinant activated factor VII (rFVIIa) was used to control severe hemorrhage secondary to alveolitis unresponsive to standard treatment. We report the case of a patient with SLE who developed severe alveolar hemorrhage unresponsive to standard

REFERENCES

1. Betensley AD, Yankansas JR. Factor VIIa for alveolar hemorrhage in microscopic polyangiitis. Am J Respir Crit Care Med 2002;166:1291-1292.

2. Santos-Ocampo AS, Mandell BF, Fessler BJ. Alveolar hemorrhage in Systemic Lupus Erythematosus: presentation and management. Chest 2000;118:1083-1090.

3. Collard HR, Schwarz MI. Diffuse alveolar hemorrhage. Crit Care Clin 2004;18:583-592.

4. Primack SL, Miller RR, Müller NL. Diffuse pulmonary hemorrhage: clinical, pathologic, and imaging features. Am J Roentgenol 1995;164:292-300.

5. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-873.

6. Raj R, Murin S, Matthay RA, Wiedemann HP. Systemic lupus erythematosus in the intensive care unit. Crit Care Clin 2002;18:781-803.

7. Barile LA, Jara LJ, Medina-Rodríguez F, et al. Pulmonary hemorrhage in systemic lupus erythematosus. Lupus 1997;6:445-448.

8. Abud-Mendoza C, Díaz Jouanen E, Alarcon-Segovia D. Fatal pulmonary hemorrhage in systemic lupus erythematosus: ocurrente without hemoptysis. J Rheumatol 1985;12:558-556.

9. Dweik RA, Arroliga AC, Cash JM. Alveolar hemorrhage in patients with rheumatic disease. Rheum Dis Clin North Am, 1997;23:395-410.

10. Lee JG, Joo KW, Chung WK, Jung YC, Zheung SH, Yoon HJ, et al. Diffuse alveolar hemorrhage in lupus nephritis. Clin Nephrol 2001;55(4):282–288.

11. Hughson MP, He Z, Henegar J, McMurray R. Alveolar hemorrhage and renal microangiopathy in systemic lupus erythematosus, Immune complex small vascular injury with apoptosis. Arch Pathol Lab Med 2001;125:475-483.

12. Balc C, Sungurtekin H, Gürses E, Sungurtekin U, Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 2003;7:85-90.

13. Meijer K, de Graaff WE, Drenen SM, van der Meer J. Successful treatment of massive hemoptysis in acute leukemia with recombinant Factor VIIa. Arch Intern Med 2000;160:2216-2217.

14. Carrillo ER, Salmeron NP, Carvajal RR, Contreras DV, Hernández AC. Rompiendo el paradigma del modelo humoral al modelo celular de la coagulación. Aplicación clínica en el enfermo grave. Rev Asoc Mex Med Crti Ter Int, 2004;18:17-23.

15. Enomoto MT, Thorborg P. Emerging off- label Uses for Recombinant Activated Factor VII: Grading the Evidence. Crit Care Clin 2005;21:611-632.

16. Hoffman M, Monroe III MD. The action of high-dose factor VIIa in a cellbased model hemostasis. Disease-a-Month 2003;49:1-7.

17. Veldman A, Hoffman M, Ehrenforth S. New Insights into the Coagulation System and Implication for New Therapeutic Options recombinant Factor VIIa. Curr Med Chem, 2003;10:797-811.

18. Pastores MS, Papadopoulus E, Voigt L, Helpern AN. Diffuse Alveolar Hemorrhage After Allogenic Hematopoietic Stem-Cell Transplantation. Treatment With Recombinant Factor VIIa. Chest 2003;124:2400-2403.

19. Hicks K, Peng D, Gajewski JL. Treatment of diffuse alveolar hemorrhage after allogenic bone marrow transplant with recombinat factor VIIa. Bone Marrow Transplant 2002;30:975-978.